Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like Forward Pharma CFO and Two VPs Step Down, Will Cut More Jobs Bringing the Number of Full-Time Employees to Seven April 30, 2017 <b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017 Editas CEO to Testify at a U.S. Senate Hearing Next Week November 7, 2017
Forward Pharma CFO and Two VPs Step Down, Will Cut More Jobs Bringing the Number of Full-Time Employees to Seven April 30, 2017
<b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017
